These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28990054)

  • 1. Diagnostic and prognostic value of serum interleukin‑16 in patients with gastric cancer.
    Yang H; Han Y; Wu L; Wu C
    Mol Med Rep; 2017 Dec; 16(6):9143-9148. PubMed ID: 28990054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.
    Liu WL; Liu D; Cheng K; Liu YJ; Xing S; Chi PD; Liu XH; Xue N; Lai YZ; Guo L; Zhang G
    Oncotarget; 2016 May; 7(19):28124-38. PubMed ID: 27058412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
    Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
    Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
    Hou CG; Luo XY; Li G
    Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
    Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
    Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
    Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
    Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
    Jiang H; Yu WW; Wang LL; Peng Y
    Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.